| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 379399 | Null | 0.0217366743178497 | 0.57959061 |
| NSC 618262 | Null | 0.0217366743178497 | 0.22515649 |
| NSC 622398 | Fascaplysine | 0.0217366743178497 | 0.18165526 |
| NSC 623527 | Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt | 0.0217366743178497 | 0.094327901 |
| NSC 628114 | 9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride | 0.0217366743178497 | 0.18968354 |
| NSC 633530 | 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- | 0.0217366743178497 | 0.14887421 |
| NSC 635000 | Null | 0.0217366743178497 | 0.30816017 |
| NSC 639512 | Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.0217366743178497 | 0.19774574 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.0217366743178497 | 0.43832763 |
| NSC 641297 | ANTINEOPLASTIC-641297 | 0.0217366743178497 | 0.029497651 |